Código QR (código de barras bidimensional)

Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders

A new approach is adopted to treat primary immunodeficiency disorders, such as the severe combined immunodeficiency (SCID; e.g., adenosine deaminase SCID [ADA-SCID] and IL-2 receptor X-linked severe combined immunodeficiency [SCID-X1]). The success, along with the feasibility of gene therapy, is und...

תיאור מלא

שמור ב:
Principais autores: Odiba Arome Solomon, Okoro Nkwachukwu Oziamara, Durojaye Olanrewaju Ayodeji, Wu Yanjun
פורמט: Artigo
שפה:Inglês
יצא לאור: De Gruyter 2021-05-01
סדרה:Open Life Sciences
נושאים:
clinical trials
gene therapy
hemoglobin
hemophilia b
neurodegenerative
ocular
גישה מקוונת:https://doi.org/10.1515/biol-2021-0033
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים